Physician

Zanetta Stewart Lamar, M.D.

According to 2025 Medicare claims, Zanetta Lamar, M.D. (NPI: 1871776757) practices hematology/oncology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 34102-5644. Lamar is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Bassett Accountable Care Partners, LLC (ACO ID: A2612), participating under the MSSP model.

Lamar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 960 traditional Medicare patients, billed 184,422 HCPCS/CPT codes, and received $2,829,702 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,023 prescription claims across 264 beneficiaries totaling $2,998,103 in drug costs, led by Ibrance (Palbociclib). DME data shows 45 claims. Open Payments data shows 141 records totaling $5,662. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $27,520 to $2,829,702. Similarly, Part D prescription costs have risen steadily, from $406,175 to $2,998,103. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2015 Medicare payment: $27,520 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $27,695 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $20,939 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $17,679 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $256,804 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,424,285 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,485,267 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,716,863 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,566,747 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,829,702 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201592370$27,520
2016140421$27,695
2017114338$20,939
2018107281$17,679
201933215,860$256,804
20201,184191,633$2,424,285
2021795190,554$2,485,267
2022790205,403$2,716,863
2023880214,140$2,566,747
2024960184,422$2,829,702

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2015 Drug cost: $406,175 (USD; Tot_Drug_Cst)2016 Drug cost: $773,931 (USD; Tot_Drug_Cst)2017 Drug cost: $870,071 (USD; Tot_Drug_Cst)2018 Drug cost: $296,634 (USD; Tot_Drug_Cst)2019 Drug cost: $409,869 (USD; Tot_Drug_Cst)2020 Drug cost: $1,310,132 (USD; Tot_Drug_Cst)2021 Drug cost: $1,996,614 (USD; Tot_Drug_Cst)2022 Drug cost: $2,137,651 (USD; Tot_Drug_Cst)2023 Drug cost: $2,177,844 (USD; Tot_Drug_Cst)2024 Drug cost: $2,998,103 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201552312$406,175
201679498$773,931
201767456$870,071
201852179$296,634
201956159$409,869
2020128535$1,310,132
2021173830$1,996,614
2022217961$2,137,651
20232591,141$2,177,844
20242641,023$2,998,103

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$776$1.6K2021 Medicare payment: $1,552 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $872 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $963 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R13$1,552
2022N/RN/RN/R
2023N/R23$872
2024N/R45$963

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more345741$98
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more489738$66
96372Injection of drug or substance under skin or into muscle157456$10
36415Insertion of needle into vein for collection of blood sample7041,734$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6851,911$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib21588$328,737
JakafiRuxolitinib Phosphate20600$312,767
RevlimidLenalidomide19490$288,425
XtandiEnzalutamide21630$250,859
BrukinsaZanubrutinib16474$235,022

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R15$499
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R14$263
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R16$201

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.140$3,412PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.1$2,250PFIZER INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Zanetta Stewart Lamar, M.D.?

Tedicare shows public-source Medicare data for Zanetta Stewart Lamar, M.D. (NPI 1871776757), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zanetta Stewart Lamar, M.D. have ACO affiliation data?

Zanetta Stewart Lamar, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612).

What billing organization is linked to Zanetta Stewart Lamar, M.D.?

Zanetta Stewart Lamar, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Zanetta Stewart Lamar, M.D. have Open Payments data?

Zanetta Stewart Lamar, M.D. has 141 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.